Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 04, 2021

SELL
$282.99 - $369.05 $183,943 - $239,882
-650 Closed
0 $0
Q2 2021

Jul 02, 2021

SELL
$259.0 - $414.71 $3.69 Million - $5.91 Million
-14,242 Reduced 95.64%
650 $225,000
Q1 2021

Apr 01, 2021

SELL
$242.95 - $284.63 $253,639 - $297,153
-1,044 Reduced 6.55%
14,892 $4.71 Million
Q4 2020

Jan 04, 2021

BUY
$236.26 - $355.63 $167,744 - $252,497
710 Added 4.66%
15,936 $3.9 Million
Q3 2020

Oct 01, 2020

BUY
$264.77 - $305.71 $24,623 - $28,431
93 Added 0.61%
15,226 $4.32 Million
Q2 2020

Jul 01, 2020

SELL
$258.66 - $342.55 $2.65 Million - $3.51 Million
-10,256 Reduced 40.4%
15,133 $4.05 Million
Q1 2020

Apr 02, 2020

BUY
$268.85 - $341.04 $2.95 Million - $3.75 Million
10,990 Added 76.32%
25,389 $8.03 Million
Q4 2019

Jan 07, 2020

SELL
$220.06 - $304.07 $2.42 Million - $3.34 Million
-10,990 Reduced 43.29%
14,399 $4.27 Million
Q3 2019

Oct 02, 2019

BUY
$217.44 - $243.88 $218,527 - $245,099
1,005 Added 4.12%
25,389 $5.91 Million
Q2 2019

Jul 01, 2019

BUY
$219.29 - $241.72 $230,693 - $254,289
1,052 Added 4.51%
24,384 $5.7 Million
Q1 2019

May 16, 2019

BUY
$216.71 - $338.96 $226,028 - $353,535
1,043 Added 4.68%
23,332 $5.52 Million
Q4 2018

Jan 17, 2019

SELL
$278.5 - $352.75 $98,867 - $125,226
-355 Reduced 1.57%
22,289 $6.71 Million
Q3 2018

Oct 25, 2018

BUY
$293.51 - $383.83 $87,465 - $114,381
298 Added 1.33%
22,644 $8 Million
Q2 2018

Jul 11, 2018

SELL
$257.52 - $306.91 $359,240 - $428,139
-1,395 Reduced 5.88%
22,346 $6.49 Million
Q1 2018

Apr 20, 2018

BUY
$260.13 - $367.91 $50,725 - $71,742
195 Added 0.83%
23,741 $6.5 Million
Q4 2017

Feb 05, 2018

SELL
$307.64 - $344.58 $131,362 - $147,135
-427 Reduced 1.78%
23,546 $7.5 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $6.74 Million - $7.9 Million
23,973
23,973 $7.51 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Thomasville National Bank Portfolio

Follow Thomasville National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomasville National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Thomasville National Bank with notifications on news.